(19)
(11) EP 4 031 657 A1

(12)

(43) Date of publication:
27.07.2022 Bulletin 2022/30

(21) Application number: 20786122.0

(22) Date of filing: 17.09.2020
(51) International Patent Classification (IPC): 
C12N 9/02(2006.01)
C12P 7/22(2006.01)
C12P 17/06(2006.01)
C12N 15/52(2006.01)
C12P 7/42(2006.01)
C12N 15/82(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/0004; C12Y 121/03007; C12P 17/06; C12P 7/42; C12N 15/52; C07K 14/415
(86) International application number:
PCT/US2020/051261
(87) International publication number:
WO 2021/055597 (25.03.2021 Gazette 2021/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 18.09.2019 US 201962902300 P

(71) Applicant: Demetrix, Inc.
Berkeley, CA 94710 (US)

(72) Inventors:
  • HORWITZ, Andrew
    Berkeley, California 94710 (US)
  • WONG, Jeff
    Berkeley, California 94710 (US)
  • PLATT, Darren
    Berkeley, California 94710 (US)
  • UBERSAX, Jeff
    Berkeley, California 94710 (US)

(74) Representative: Cooley (UK) LLP 
22 Bishopsgate
London EC2N 4BQ
London EC2N 4BQ (GB)

   


(54) OPTIMIZED TETRAHYDROCANNABINOLIC ACID (THCA) SYNTHASE POLYPEPTIDES